Who We Are

We are a pre-clinical stage biotechnology startup developing the next generation of nanomedicines based on a proprietary glycogen nanoparticle technology platform - NanoDendrix™

We are world-class physicists, chemists, and biologists, led by a talented management team and an experienced board of directors. 

We are a wholly-owned subsidiary of Mirexus Biotechnologies Inc. 

©2020 Glysantis